Acknowledgements
We also thank Genomas Inc., Hartford, CT, and the UPR-MSC RCMI Center for Genomics in Health Disparities and Rare Disorders for their support and for providing the resources and facilities for performing genetic assays.
Disclaimer
The contents of this publication are solely the responsibility of the authors and do not represent the official views of the VA Caribbean Healthcare System, the Department of Veterans Affairs, the NIH or the United States Government.
Financial & competing interests disclosure
G Ruaño is founder and President of Genomas Inc. J Duconge also holds a without compensation (WOC) employment status with the Pharmacy Service, VA Caribbean Healthcare Systems (VACHS), in San Juan, Puerto Rico. The material presented herein is the result of work supported in part by the grant number SC1 HL123911 from the National Heart, Lung, and Blood Institute (NHLBI), with resources from and the use of facilities at the Veteran Affairs Caribbean Health System (VACHS) in San Juan, Puerto Rico. Genomas, Inc. provided support in the form of salaries for G Ruaño, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of this letter. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.